[go: up one dir, main page]

DE60105614D1 - Oxazinochinolone für die behandlung viraler infektionen - Google Patents

Oxazinochinolone für die behandlung viraler infektionen

Info

Publication number
DE60105614D1
DE60105614D1 DE60105614T DE60105614T DE60105614D1 DE 60105614 D1 DE60105614 D1 DE 60105614D1 DE 60105614 T DE60105614 T DE 60105614T DE 60105614 T DE60105614 T DE 60105614T DE 60105614 D1 DE60105614 D1 DE 60105614D1
Authority
DE
Germany
Prior art keywords
oxazinochinolone
treatment
viral infections
infections
viral
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE60105614T
Other languages
English (en)
Other versions
DE60105614T2 (de
Inventor
Suvit Thaisrivongs
R Turner
Atli Thorarensen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pharmacia and Upjohn Co
Original Assignee
Pharmacia and Upjohn Co
Upjohn Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia and Upjohn Co, Upjohn Co filed Critical Pharmacia and Upjohn Co
Application granted granted Critical
Publication of DE60105614D1 publication Critical patent/DE60105614D1/de
Publication of DE60105614T2 publication Critical patent/DE60105614T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D498/06—Peri-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D498/10—Spiro-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
    • C07D498/20—Spiro-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Communicable Diseases (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Oncology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
DE60105614T 2000-07-12 2001-06-29 Oxazinochinolone für die behandlung viraler infektionen Expired - Fee Related DE60105614T2 (de)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US21755500P 2000-07-12 2000-07-12
US217555P 2000-07-12
US26221101P 2001-01-17 2001-01-17
US262211P 2001-01-17
US26825501P 2001-02-13 2001-02-13
US268255P 2001-02-13
PCT/US2001/016507 WO2002004462A1 (en) 2000-07-12 2001-06-29 Oxazinoquinolones useful for the treatment of viral infections

Publications (2)

Publication Number Publication Date
DE60105614D1 true DE60105614D1 (de) 2004-10-21
DE60105614T2 DE60105614T2 (de) 2005-10-06

Family

ID=27396428

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60105614T Expired - Fee Related DE60105614T2 (de) 2000-07-12 2001-06-29 Oxazinochinolone für die behandlung viraler infektionen

Country Status (11)

Country Link
EP (1) EP1299395B1 (de)
JP (1) JP2004502777A (de)
AR (1) AR030304A1 (de)
AT (1) ATE276262T1 (de)
AU (1) AU2001269704A1 (de)
DE (1) DE60105614T2 (de)
ES (1) ES2227232T3 (de)
PE (1) PE20020189A1 (de)
PT (1) PT1299395E (de)
TR (1) TR200402534T4 (de)
WO (1) WO2002004462A1 (de)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6821969B2 (en) 2001-02-13 2004-11-23 Pharmacia & Upjohn Company Thioxazinoquinolones as antiviral agents
MXPA05010776A (es) * 2003-04-07 2006-05-25 Cylene Pharmaceuticals Inc Analogos sustituidos de quinobenzoxazina.
MX2008011633A (es) 2006-03-13 2008-12-16 Activx Biosciences Inc Aminoquinolonas como inhibidores de gsk-3.
US8389514B2 (en) 2007-09-11 2013-03-05 Kyorin Pharmaceutical Co., Ltd. Cyanoaminoquinolones and tetrazoloaminoquinolones as GSK-3 inhibitors
JP5373799B2 (ja) 2007-09-12 2013-12-18 杏林製薬株式会社 Ｇｓｋ−３阻害剤としてのスピロ環式アミノキノロン
US8071591B2 (en) 2009-03-11 2011-12-06 Kyorin Pharmaceutical Co., Ltd. 7-cycloalkylaminoquinolones as GSK-3 inhibitors
SG11201502369XA (en) 2012-10-16 2015-05-28 Janssen Pharmaceutica Nv Methylene linked quinolinyl modulators of ror-gamma-t
WO2014062655A1 (en) 2012-10-16 2014-04-24 Janssen Pharmaceutica Nv HETEROARYL LINKED QUINOLINYL MODULATORS OF RORyt
ES2628365T3 (es) 2012-10-16 2017-08-02 Janssen Pharmaceutica N.V. Moduladores de quinolinilo unidos a fenilo de ROR-GAMA-T
US10555941B2 (en) 2013-10-15 2020-02-11 Janssen Pharmaceutica Nv Alkyl linked quinolinyl modulators of RORγt
US9284308B2 (en) 2013-10-15 2016-03-15 Janssen Pharmaceutica Nv Methylene linked quinolinyl modulators of RORγt
KR20160068956A (ko) 2013-10-15 2016-06-15 얀센 파마슈티카 엔.브이. RORyT의 퀴놀리닐 조절제
US9221804B2 (en) 2013-10-15 2015-12-29 Janssen Pharmaceutica Nv Secondary alcohol quinolinyl modulators of RORγt
US9328095B2 (en) 2013-10-15 2016-05-03 Janssen Pharmaceutica Nv Heteroaryl linked quinolinyl modulators of RORgammat
KR20160070133A (ko) 2013-10-15 2016-06-17 얀센 파마슈티카 엔.브이. RORyt의 알킬 결합 퀴놀리닐 조절제
US9403816B2 (en) 2013-10-15 2016-08-02 Janssen Pharmaceutica Nv Phenyl linked quinolinyl modulators of RORγt
US11072610B2 (en) 2018-09-12 2021-07-27 Novartis Ag Antiviral pyridopyrazinedione compounds
CN120842223A (zh) 2019-09-26 2025-10-28 诺华股份有限公司 抗病毒吡唑并吡啶酮化合物

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4959363A (en) * 1989-06-23 1990-09-25 Sterling Drug Inc. Quinolonecarboxamide compounds, their preparation and use as antivirals.
US5792774A (en) * 1996-02-21 1998-08-11 Chiroscience Limited Quinolones and their therapeutic use
WO1999040093A2 (en) * 1998-02-04 1999-08-12 Board Of Regents, The University Of Texas System Synthesis of quinobenzoxazine analogues with topoisomerase ii and quadruplex interactions for use as antineoplastic agents
US6248739B1 (en) * 1999-01-08 2001-06-19 Pharmacia & Upjohn Company Quinolinecarboxamides as antiviral agents
TW500724B (en) * 1999-10-05 2002-09-01 Pharmacia & Amp Upjohn Company Oxazinoquinolones useful for the treatment of viral infections

Also Published As

Publication number Publication date
PT1299395E (pt) 2005-01-31
ES2227232T3 (es) 2005-04-01
TR200402534T4 (tr) 2004-12-21
DE60105614T2 (de) 2005-10-06
JP2004502777A (ja) 2004-01-29
EP1299395B1 (de) 2004-09-15
ATE276262T1 (de) 2004-10-15
AR030304A1 (es) 2003-08-20
AU2001269704A1 (en) 2002-01-21
PE20020189A1 (es) 2002-03-02
EP1299395A1 (de) 2003-04-09
WO2002004462A1 (en) 2002-01-17

Similar Documents

Publication Publication Date Title
DE60325498D1 (de) 1-acyl-pyrrolidin-derivate für die behandlung von viralen infektionen
ATE345331T1 (de) Verbindungen verwendbar für die behandlung von entzündungskrankheiten
ATE439844T1 (de) Kombinationen für die behandlung entzündlicher erkrankungen
DE60218493D1 (de) Substituierte 7-aza-ä2.2.1übicycloheptane für die behandlung von krankheiten
ATE551340T1 (de) Azabicyclisch- substituierte annelierte heteroaryl-verbinungen für die behandlung von krankheiten
DE60105614D1 (de) Oxazinochinolone für die behandlung viraler infektionen
DE60124302D1 (de) Thiazolderivate zur behandlung von ppar-lierte krankheiten
ATE312117T1 (de) Verbindungen für die behandlung von ischämie
ATE502642T1 (de) Kombinationen für die behandlung von immun- entzündlichen erkrankungen
ATE457998T1 (de) Abgeschwächte mikroorganismen für die behandlung von infektionen
DE60136477D1 (de) Retinoide zur behandlung von emphysem
DE60236218D1 (de) CCR5 Antagonisten verwendbar für die Behandlung von Aids
DE60016047D1 (de) Dihydrobenzopyrane, dihydrobenzothiopyrane und tetrahydrochinoline zur behandlung cox-2-abhängiger krankheiten
DE60006412D1 (de) Oxazinochinolone zur behandlung von viralen infektionen
DE60103685D1 (de) Behandlung von Poriomania
NO20032769L (no) Kombinasjonsmetode for behandling av virale infeksjoner
PT1268482E (pt) Piranoindois para o tratamento de glaucoma
DE60133596D1 (de) S-Methyl-Dihydro-Ziprasidone für die Behandlung von Schizophrenie
ATE251167T1 (de) Oxazinocarbazole zur behandlung von cns- erkrankungen
ATE277924T1 (de) Aryl-8-azabicyclo(3.2.1)octanes für die behandlung von depression
FI20010472A0 (fi) Menetelmä alfa-pineenin hydraamiseksi
DE60218529D1 (de) Isochroman verbindungen für die behandlung von cns-krankheiten
ATE253556T1 (de) Aminoacylaroylpyrrole für die behandlung des neuropathischen schmerzes
DE60114448D1 (de) Imidazolonderivate zur behandlung viraler krankheiten
IS6626A (is) Kristallskenndur meðferðarmiðill

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee